List of articles with "Glioblastoma"

Curasight Trial Launch

Curasight Trial Launch

Denmark Copenhagen Glioblastoma Curasight uTREAT
Curasight's uTREAT® Trial

Curasight's uTREAT® Trial

Denmark Copenhagen Glioblastoma Curasight uTREAT
Enhancing Glioblastoma Treatment

Enhancing Glioblastoma Treatment

USA Glioblastoma Missoula FYR Bio NuvOx Therapeutics
Preclinical Breakthrough

Preclinical Breakthrough

USA Glioblastoma Vascarta Summit CUNY
FDA Fast Track for MT-125

FDA Fast Track for MT-125

USA Jupiter Glioblastoma Myosin Therapeutics MT-125
Phase I Trial Recruitment

Phase I Trial Recruitment

Australia Glioblastoma Brisbane Cyteph Ltd CYT-101
PNM Receives Orphan Drug Status

PNM Receives Orphan Drug Status

USA Redwood City Glioblastoma FDA Orphan Drug Precision NeuroMed
Glioblastomas' Wide Impact

Glioblastomas' Wide Impact

United States Cancer Research Glioblastoma Bronx Immune Response
Myosin's $4.5M Grant

Myosin's $4.5M Grant

USA Jupiter Glioblastoma Myosin Therapeutics MT-125
GLIX1 FDA Clearance

GLIX1 FDA Clearance

Glioblastoma Norway Oslo GLIX1 Hemispherian
DOC1021 Phase 2 Trial

DOC1021 Phase 2 Trial

USA Los Angeles Glioblastoma Diakonos Oncology DOC1021
Innovating Glioblastoma Treatment

Innovating Glioblastoma Treatment

USA Palo Alto Glioblastoma SandboxAQ iOncologi
Myosin's New Cancer Therapies

Myosin's New Cancer Therapies

USA Jupiter cancer therapies Glioblastoma Myosin Therapeutics
MT-125 Trial Approval

MT-125 Trial Approval

United States Jupiter Glioblastoma Myosin Therapeutics MT-125
Phase I Results of DOC1021

Phase I Results of DOC1021

USA Houston Glioblastoma Diakonos Oncology Dubodencel
Lucicebtide Updates

Lucicebtide Updates

United States Chicago Glioblastoma Sapience Therapeutics Lucicebtide
Diakonos Raises $20 Million

Diakonos Raises $20 Million

United States Houston Immunotherapy Glioblastoma Diakonos Oncology
Diakonos at ASCO 2025

Diakonos at ASCO 2025

United States Glioblastoma Chicago, Illinois Diakonos Oncology DOC1021
Alpheus Medical Fundraise

Alpheus Medical Fundraise

United States Alpheus Medical Sonodynamic Therapy Chanhassen Glioblastoma
Lucicebtide at ASCO 2025

Lucicebtide at ASCO 2025

USA Glioblastoma Sapience Therapeutics Tarrytown Lucicebtide
Elpis CAR-T Innovations

Elpis CAR-T Innovations

USA Glioblastoma CAR-T therapy Lexington Elpis Biopharmaceuticals
Symphony Robotics and Dr. Martin

Symphony Robotics and Dr. Martin

USA Miami Glioblastoma Symphony Robotics Dr. Neil Martin
DOC1021 at AAN 2025

DOC1021 at AAN 2025

USA San Diego Glioblastoma Diakonos Oncology DOC1021
OSR Holdings $80M Deal

OSR Holdings $80M Deal

None Glioblastoma OSR Holdings White Lion Fund
LAM561 Promising Results

LAM561 Promising Results

Spain Glioblastoma Laminar Pharma LAM561 Palma de Mallorca
Sonodynamic Therapy Breakthrough

Sonodynamic Therapy Breakthrough

USA Alpheus Medical Sonodynamic Therapy Chanhassen Glioblastoma
MimiVax SurVaxM Trial

MimiVax SurVaxM Trial

United States Glioblastoma Buffalo MimiVax SurVaxM
Brain Cancer Innovations

Brain Cancer Innovations

United States Glioblastoma Mountain View Cordance Medical EXACT Therapeutics
Rznomics EAP Launch

Rznomics EAP Launch

South Korea Rznomics RZ-001 Glioblastoma Seongnam

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.